Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02723097

A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)

Post Traumatic Stress Disorder (PTSD) Clinical Trial

Official title:
A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)

Clinical Trial Summary

The objective of this protocol is to test the feasibility and acceptability of the Relaxation Response Resiliency Program (3RP), a psychotherapy treatment providing a variety of mind body skills and interventions to decrease medical and mental health symptoms and build resilience, in Spanish-speaking World Trade Center (WTC) survivors, and to examine its clinical effectiveness to reduce Post Traumatic Stress Disorder (PTSD), depression, anxiety, and lower respiratory symptoms (LRS) and improve psychosocial functioning.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02723097
Study type Interventional
Source New York University School of Medicine
Contact
Status Completed
Phase N/A
Start date March 1, 2016
Completion date October 11, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT00554177 - A Clinical Trial for Post Traumatic Stress Disorder Phase 1
Recruiting NCT01545505 - Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse N/A
Completed NCT02966873 - Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD) Phase 2
Completed NCT04827056 - Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Phase 1
Completed NCT04073862 - The Norwegian Stepped-Care TF-CBT Study N/A
Recruiting NCT05254379 - Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain N/A
Terminated NCT02077972 - Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD) N/A
Completed NCT04086654 - Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD N/A
Completed NCT01629537 - A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder Phase 2
Withdrawn NCT00641511 - Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD) Phase 2
Recruiting NCT04558437 - COVID-Impact "Psychological IMPACT of Covid-19 on AP-HP Staff"
Not yet recruiting NCT06162741 - Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans N/A
Completed NCT02764983 - Occupational Therapy Driving Intervention for Returning Combat Veterans. N/A
Completed NCT02765672 - Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans N/A
Not yet recruiting NCT06335407 - Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study Phase 1